Moomoo AI 已提取核心信息
AdvisorShares Trust, an investment company registered under Section 8 of the Investment Company Act of 1940, has filed a Schedule 13G with the United States Securities and Exchange Commission on February 14, 2024, indicating a significant ownership stake in Clearmind Medicine Inc. The filing, which is required due to the event that occurred on December 31, 2023, shows that AdvisorShares Trust holds 92,693 common shares of Clearmind Medicine, representing 5.48% of the company's class of securities. The shares are held with sole voting and dispositive power, suggesting that AdvisorShares Trust has both the right to vote and the right to dispose of the shares. The address of Clearmind Medicine's principal executive offices is listed as 101 – 1220 W 6 Ave, Vancouver BC, Canada. The filing asserts that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of Clearmind Medicine.
AdvisorShares Trust, an investment company registered under Section 8 of the Investment Company Act of 1940, has filed a Schedule 13G with the United States Securities and Exchange Commission on February 14, 2024, indicating a significant ownership stake in Clearmind Medicine Inc. The filing, which is required due to the event that occurred on December 31, 2023, shows that AdvisorShares Trust holds 92,693 common shares of Clearmind Medicine, representing 5.48% of the company's class of securities. The shares are held with sole voting and dispositive power, suggesting that AdvisorShares Trust has both the right to vote and the right to dispose of the shares. The address of Clearmind Medicine's principal executive offices is listed as 101 – 1220 W 6 Ave, Vancouver BC, Canada. The filing asserts that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of Clearmind Medicine.
根据1940年《投资公司法》第8条注册的投资公司AdvisorShares Trust已于2024年2月14日向美国证券交易委员会提交了附表13G，表示拥有Clearmind Medicine Inc.的重要所有权。该文件是根据2023年12月31日发生的事件而必须提交的，显示AdvisorShares Trust持有Clearmind Medicine 92,693股普通股，占该公司5.48％ 证券类别。这些股票以唯一的投票权和处置权持有，这表明AdvisorShares Trust既有投票权，也有处置股份的权利。Clearmind Medicine的主要行政办公室地址列为加拿大不列颠哥伦比亚省温哥华市西6大道101—1220号。该文件称，这些股份是在正常业务过程中收购的，不是为了改变或影响Clearmind Medicine的控制权。
根据1940年《投资公司法》第8条注册的投资公司AdvisorShares Trust已于2024年2月14日向美国证券交易委员会提交了附表13G，表示拥有Clearmind Medicine Inc.的重要所有权。该文件是根据2023年12月31日发生的事件而必须提交的，显示AdvisorShares Trust持有Clearmind Medicine 92,693股普通股，占该公司5.48％ 证券类别。这些股票以唯一的投票权和处置权持有，这表明AdvisorShares Trust既有投票权，也有处置股份的权利。Clearmind Medicine的主要行政办公室地址列为加拿大不列颠哥伦比亚省温哥华市西6大道101—1220号。该文件称，这些股份是在正常业务过程中收购的，不是为了改变或影响Clearmind Medicine的控制权。
有用
没用